Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events eu grants largest project safety evaluation drugs used treatment diabetes
… within the last 6 months, or in patients with concomitant treatment with two or more additional antiplatelet agents … all study populations, and use of 2 or more antiplatelet drugs decreased in the United Kingdom, Spain, and Sweden. …
… that information in designing a clinical trial. Image This project will represent the first time patient preference on … and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Our initiatives improve …
… economics Literature Reviews: Disease, burden of illness, treatment pathway, epidemiology and unmet need A Gap … Clinical, economic, PRO /QoL value A Roadmap: Tactical project and study recommendations for filling the gaps Market …
… Pooled Data Analysis of Long-Term Treatment Effect OPPORTUNITY Our client had a treatment for kidney disease that had been shown to slow … short-term clinical studies. They wanted to assess their treatment compared with standard of care on the annual rate …
… (NMA) is a standard statistical network analysis method used in health technology assessments (HTA) for regulatory … network of evidence to estimate the relative difference in treatment effect of drugs or medical devices. NMA methodology is an active area …
… - the birthplace of Coca-Cola, the home of the world's largest drive-in restaurant (The Varsity), the city with over …
… diseases related to men's health, or complications of treatment in men's health. Our experience includes: Benign … and gain market access for products that demonstrate treatment benefits in men's health. Recent projects have … Reimbursement dossiers (i.e., AMCP) Survey development, evaluation and implementation Treatment patterns and patient …
… Research (HEOR) Strategy Plans and Gap Analyses for a Treatment Targeting Multiple Rare Diseases OPPORTUNITY Our … product in multiple phase 2 and 3 clinical trials for the treatment of numerous rare disease indications (chronic … value proposition and potential value messages (efficacy, safety, humanistic/quality of life, economic, and dosing …
… change to the marketing authorization process in the EU. It is critical that drug and device developers become … models target population patient subgroups positioning in treatment pathway Evidence strategy clinical trial design … payer-relevant endpoints control arm selection indirect treatment comparison strategy synthetic control arms …
… Mond T, Marshall G, Sweeney C, Davenport E, Wang J. @AANP_NEWS #AANP23 …